George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: HL CFO to depart; Novacyt hires CEO from Amryt

Thu, 29th Jul 2021 17:10

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

----------

Hargreaves Lansdown PLC - Bristol-based wealth management platform - Chief Financial Officer Philip Johnson will step down for "personal reasons" after a transition. HL now will search for a successor.

----------

Pearson PLC - London-based education publisher - Elizabeth Corley will step down as non-executive director after being named the next chair of asset manager Schroders PLC. Corley will join the Schroders board on September 1, at which time she will step down as chair of the Pearson board's Remuneration Committee. Corley will step down from the Pearson board itself before becoming assuming the Schroders chair after the Schroders annual general meeting on April 28, 2022. Until 2016, Corley was chief executive of Allianz Global Investors. She previously was a consulting partner for Merrill Lynch Investment Managers and Coopers & Lybrand.

----------

Jupiter Fund Management PLC - London-based long-term, active investor - Hires Dale Murray as independent non-executive director, starting September 1. Murray co-founded mobile telecommunications software firm Omega Logic and led the business after its takeover by First Data Corp, before becoming an angel investor in the digital sector.

----------

Novacyt SA - Surrey-based biotechnology group focused on clinical diagnostics - Hires David Allmond as chief executive officer and director, starting October 18 and replacing Graham Mullis, who will retire after 13 years with the company and a predecessor. Allmond is chief business officer at fellow AIM listing Amryt Pharma PLC.

----------

Stock Spirits Group PLC - branded spirits and liqueurs in Central and Eastern Europe and Italy - Hires Juliette Stacey as independent non-executive director. Stacey is senior independent director of pub chain Fuller, Smith & Turner PLC and as an executive was chief operating officer, Commercial UK & Europe, for estate agent Savills PLC.

----------

C&C Group PLC - Dublin-based beer, cider, wine, spirits and soft drinks - Chief Operating Officer Andrea Pozzi will step down from the board on September 1 but will remain with C&C to manage its GB businesses trading under the Tennent's brand. The executive director role of COO will be divided among other executive directors. Meanwhile, Jim Clerkin will step down as non-executive director on October 27 after four years to focus on work responsibilities in the US.

----------

IQE PLC - Cardiff-based semiconductor wafers and materials - Hires Victoria Hull as non-executive director, starting on Sunday. Hull is senior independent director of FTSE 250-constituent Ultra Electronics Holdings PLC and also is on the boards of Network International Holdings PLC and Alphawave IP Group PLC.

----------

ADM Energy PLC - investor with producing interests in Nigeria - Hires Oliver Andrews as non-executive chair, starting on Monday next week. Andrews replaces Peter Francis, who will step down from the board on Monday for "personal circumstances". Andrews was chief investment officer at natural resources and infrastructure investor Africa Finance Corp.

----------

Seplat Energy PLC - Hires Emma FitzGerald as independent non-executive director, starting August 1 and replacing Mark Malloch-Brown. FitzGerald is a former executive at oil major Royal Dutch Shell PLC, power distributor National Grid PLC and water works Severn Trent PLC.

----------

TR European Growth Trust PLC - Janus Henderson-managed fund that seeks capital growth by investing in smaller and medium sized in Europe outside the UK - Promotes Simona Heidempergher to senior independent director, starting immediately. Heidempergher has been one of the trust's European-based directors since 2014. She is managing director of Merifin Capital and lead independent director of Milan-listed Aquafil Spa.

----------

Argo Blockchain PLC - London-based cryptocurrency mining - Refreshes board by hiring Colleen Sullivan, Maria Perrella, and Sarah Gow as independent non-executive directors, and adding Alex Appleton as executive director. Meanwhile, Peter Wall will be interim chair as well as CEO until a new chair is found. The new appointments replace Ian Macleod as executive chair and James Savage and Marco D'Attanasio as non-executive directors. Sullivan is CEO of CMT Digital, part of CMT Group, specialising in crypto-asset trading and blockchain technology investments. Perrella was CFO of MDA, a Canadian space mission partner. Gow spent 11 years at Citigroup Asset Management, serving as director of Global Operations in New York and head of Operations in London. Appleton has been Argo Blockchain's finance director since September last year.

----------

Anglesey Mining PLC - developing Parys Mountain copper-zinc-lead deposit in northern Wales - Hires Jo Battershill as chief executive, starting on Sunday. Battershill has been a broker at Canaccord Genuity Group Inc and UBS Group AG for the past 13 years, ending as head of Sales & Distribution of Australian equities in the Europe, Middle East and Africa region for Canaccord. He previously had worked in mining operations at Western Mining Corp in Australia. Battershill replaces Bill Hooley, who moves to deputy chair, also from Sunday. Speaking to two other "senior minerals industry professionals" to become non-executive directors. Anglesey will hold its AGM on September 30 but its results for the financial year that ended March 31 will be delayed by up to two months in order to complete the audit. Anglesey says it knows of no material issues with the accounts, and the delay is due to the difficulties caused by the Covid-19 pandemic.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Jan 2022 14:39

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

IN BRIEF: Amryt Pharma delists from AIM as trading shifts to New York

Read more
22 Nov 2021 11:37

Amryt to delist from AIM, concentrate on Nasdaq trading

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced its intention to cancel its shares from trading on AIM on Monday, with effect on 11 January.

Read more
9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Read more
19 Oct 2021 15:54

Amryt Pharma granted another two US patents

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma updated the market on patents for its lead development candidate 'Oleogel-S10' on Tuesday, as well as its recently-acquired and third commercial product 'Mycapssa'.

Read more
14 Sep 2021 07:32

IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition

IN BRIEF: Amryt Pharma ups guidance again after Chiasma acquisition

Read more
6 Aug 2021 14:41

IN BRIEF: Amryt hikes guidance on record second quarter results

IN BRIEF: Amryt hikes guidance on record second quarter results

Read more
6 Aug 2021 12:02

Record second quarter sees Amryt lift guidance further

(Sharecast News) - Amryt Pharma reported record second quarter results on Friday, raising its full-year guidance, as revenue in the three months ended 30 June came in at $62.8m, up from $46.2m year-on-year.

Read more
17 Jun 2021 14:34

Cathal Friel-led Poolbeg Pharma set to float on AIM

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising the funds needed to develop its product pipeline.

Read more
3 Jun 2021 19:20

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

Read more
3 Jun 2021 11:26

FDA grants Amryt's Oleogel-S10 priority review status

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced on Thursday that the United States Food and Drug Administration (FDA) has granted priority review status for the new drug application for 'Oleogel-S10', for the treatment of epidermolysis bullosa (EB).

Read more
2 Jun 2021 19:10

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

Read more
5 May 2021 19:20

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

Read more
6 Apr 2021 14:54

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

Read more
31 Mar 2021 11:50

Amryt completes rolling FDA submission for Oleogel-S10

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has completed the rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for 'Oleogel-S10', it announced on Wednesday, for the potential treatment of cutaneous manifestations of junctional and dystrophic epidermolysis bullosa (EB).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.